≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of ureter, including Hilmo

Endpoint Browser PheWeb

C3_URETER_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C66
  • Hospital discharge: ICD-9 — 189[2-3]
  • Hospital discharge: ICD-8 — 1892
  • Cause of death: ICD-10 — C66
  • Cause of death: ICD-9 — 189[2-3]
  • Cause of death: ICD-8 — 1892
  • Cancer registry: Topography ICD-O-3 — C66
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

294

4. Check minimum number of events

None

294

5. Include endpoints

None

294

6. Filter based on genotype QC (FinnGen only)

281

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 281 79 202
Unadjusted period prevalence (%) 0.07 0.03 0.09
Median age at first event (years) 73.11 73.42 72.99

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
294
Matched controls
2940
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
307.7
275
*
UKB02
NOMESCO Finland
Retrograde ureteroscopy
194.2
252.9
124
11
UKC02
NOMESCO Finland
Cystoscopy
55.8
223.8
259
344
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
184.4
157
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
839.8
153.7
138
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
67.1
152.5
86
18
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
64.9
148.1
84
18
R31
ICD-10 Finland
Unspecified haematuria
18.3
147.8
178
228
WX302
NOMESCO Finland
Thoracal epidural anesthesy
36.6
104.2
68
24
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
1306.6
99.1
91
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
451.2
98.3
93
*
H02AB02
ATC
dexamethasone; systemic
46.9
94.6
57
15
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
+∞
92.7
84
*
130
Kela drug reimbursment
Malignant tumour
+∞
90.4
82
*
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
86.9
79
*
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
47.3
85.0
51
13
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
20.6
84.9
70
44
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
83.4
76
*
8120/3-C66.9
ICD-O-3
Transitional cell carcinoma, NOS, of ureter
+∞
81.1
74
*
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
+∞
71.9
66
*
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
179.4
68.3
69
5
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
67.3
62
*
KH1AD
NOMESCO Finland
CT of urinary organs
18.0
64.8
56
38
Z51.5
ICD-10 Finland
Palliative care
14.6
64.0
63
54
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
63.9
59
*
JN4AD
NOMESCO Finland
Body CT examination
11.1
63.2
77
91
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
10.4
59.6
76
95
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
59.4
55
*
JN4BD
NOMESCO Finland
Extensive body CT
11.6
59.4
69
76
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
669.7
57.7
55
*
B01AB10
ATC
tinzaparin; parenteral
9.4
56.9
80
113
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
114.8
53.0
56
6
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
214.5
52.8
53
*
A04AA01
ATC
ondansetron; systemic, rectal
20.6
51.7
41
23
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
49.4
46
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
74.7
49.3
55
9
JN4CD
NOMESCO Finland
Very extensive body CT
22.1
48.4
37
19
A03FA01
ATC
metoclopramide; systemic, rectal
6.8
46.1
89
176
XX3DW
NOMESCO Finland
Time consuming IT work
10.9
45.3
53
58
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
68.1
45.1
51
9
WX408
NOMESCO Finland
General anesthesy, balanced
5.4
45.0
133
387
TPH07
NOMESCO Finland
Cathetrisation of artery
6.6
45.0
90
184
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
13.8
42.8
42
35
KBD00
NOMESCO Finland
Partial excision of ureter
+∞
41.7
39
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
417.4
37.9
37
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
5.1
37.4
105
287
ZX136
NOMESCO Finland
Intravesicalis
404.4
36.8
36
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
36.2
34
*
WX402
NOMESCO Finland
General anaesthesia
5.2
35.6
94
243
J01MA02
ATC
ciprofloxacin; systemic
4.6
35.5
190
841
KA1AE
NOMESCO Finland
Kidney ultrasound examination
12.7
35.1
36
32
TKC20
NOMESCO Finland
Catheterisation of bladder
6.6
34.6
64
119
KBH20
NOMESCO Finland
Replantation of ureter
361.1
32.5
32
*
U06
ICPC
Haematuria
12.3
31.7
33
30
WF049
NOMESCO Finland
Radiotherapy of metastasis
348.0
31.5
31
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.2
31.4
124
433
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
30.8
29
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.1
30.0
77
192
WZC30
NOMESCO Finland
Teaching
5.1
29.8
75
184
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
29.7
28
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
29.7
28
*
JN3AD
NOMESCO Finland
Abdominal CT examination
5.5
29.0
66
148
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.7
29.0
85
236
KBB00
NOMESCO Finland
Biopsy of ureter
+∞
28.6
27
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
28.6
27
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.5
28.4
90
265
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
86.4
28.4
31
*
116
Kela drug reimbursment
Prostate cancer
+∞
27.5
26
*
KA3EB
NOMESCO Finland
Antegrade pyelography
+∞
26.5
25
*
N02AA05
ATC
oxycodone; systemic
4.2
26.2
89
274
B01AB05
ATC
enoxaparin; parenteral
3.6
25.8
137
572
8130/2-C66.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of ureter
+∞
25.4
24
*
KC1GB
NOMESCO Finland
Cystography with X-ray
142.1
25.0
26
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
24.3
23
*
J01EA01
ATC
trimethoprim; systemic
3.7
24.0
105
383
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
23.2
22
*
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
23.2
22
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.1
22.3
75
227
8120/3-C65.9
ICD-O-3
Transitional cell carcinoma, NOS, of renal pelvis
+∞
22.2
21
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
22.0
103
390
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
+∞
21.1
20
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
21.1
20
*
WX320
NOMESCO Finland
Spinalanesthesy
3.3
20.8
115
480
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.5
20.8
28
36
XKD00
NOMESCO Finland
Uroflowmetry
3.4
20.0
99
385
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
20.0
19
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
20.0
19
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
78.8
20.0
22
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
213.8
19.8
20
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.5
19.5
86
311
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.4
19.1
29
43
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
19.0
18
*
U76
ICPC
Malignant neoplasm of bladder
+∞
19.0
18
*
KBV10
NOMESCO Finland
Removal of stent from ureter
47.4
18.5
22
5
J01MA12
ATC
levofloxacin; systemic
3.3
18.5
90
345
ZXE00
NOMESCO Finland
One hour or less
2.9
18.3
144
725
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
56.3
18.2
21
*
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
71.2
18.0
20
*
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
+∞
17.9
17
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
17.9
17
*
N30.0
ICD-10 Finland
Acute cystitis
3.7
17.2
63
200
WF002
NOMESCO Finland
Radical radiotherapy
67.4
16.9
19
*
ZXC20
NOMESCO Finland
Use of chemical agents
17.7
16.9
26
16
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
16.8
16
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
16.8
16
*
Z3231
NOMESCO Finland
Registered nurse
2.9
16.5
107
480
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
15.9
134
687
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
23.6
15.8
22
10
A79
ICPC
Malignancy NOS
+∞
15.8
15
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
15.8
15
*
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
6.7
15.7
26
42
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
168.6
15.6
16
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
40.4
15.6
19
5
KCB00
NOMESCO Finland
Biopsy of bladder
84.4
14.7
16
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
14.7
14
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
14.7
14
*
KBD22
NOMESCO Finland
Retrograde ureteroscopic destruction of tumour of ureter
+∞
14.7
14
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
157.5
14.6
15
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
44.9
14.3
17
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
6.0
14.1
26
47
ZX120
NOMESCO Finland
Intravenous
4.3
14.0
39
101
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.8
13.8
47
141
KA3GB
NOMESCO Finland
Retrograde pyelography
78.9
13.7
15
*
L02BB03
ATC
bicalutamide; oral
+∞
13.6
13
*
Y77
ICPC
Malignant neoplasm prostate
146.5
13.6
14
*
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
146.5
13.6
14
*
R4110
NOMESCO Finland
Physiotherapy
2.6
13.0
98
467
ZX090
NOMESCO Finland
Other technic of radiotherapy
52.5
13.0
15
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
5.5
12.9
26
51
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
11.8
12.8
23
21
KCW96
NOMESCO Finland
Other operations on bladder
33.7
12.7
16
5
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.6
12
*
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
+∞
12.6
12
*
A04AD12
ATC
aprepitant; systemic
+∞
12.6
12
*
115
Kela drug reimbursment
Breast cancer
+∞
12.6
12
*
L03AA02
ATC
filgrastim; parenteral
+∞
12.6
12
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.7
12.5
25
28
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
17.3
11.8
18
11
L03AA13
ATC
pegfilgrastim; parenteral
67.7
11.7
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
11.6
167
1054
C68.0
ICD-10 Finland
Malignant neoplasm: Urethra
+∞
11.5
11
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
11.5
11
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.4
11.5
45
148
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.5
11.5
23
45
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
11.3
132
759
ZXC15
NOMESCO Finland
Use of photodynamic technique
16.3
11.0
17
11
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.3
10.9
44
147
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
14.9
10.6
17
12
L02BG04
ATC
letrozole; oral
+∞
10.5
10
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
10.5
10
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
10.5
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.5
10
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
10.5
10
*
B02AA02
ATC
tranexamic acid; systemic
3.5
10.4
39
124
Z2221
NOMESCO Finland
Medical doctor
2.4
10.3
89
446
Z3226
NOMESCO Finland
Physiotherapist
2.6
10.1
67
295
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.2
10.0
20
23
TJF80
NOMESCO Finland
Ostomy education
56.9
9.7
11
*
GD1AD
NOMESCO Finland
Thorax CT examination
4.0
9.6
28
75
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
31.2
9.5
12
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.8
9.5
22
49
NK6AN
NOMESCO Finland
Total body bone isotope imaging
103.2
9.5
10
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
KBC00
NOMESCO Finland
Ureterectomy
+∞
9.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
9.4
9
*
8120/3-C68.9
ICD-O-3
Transitional cell carcinoma, NOS, of urinary system, NOS
+∞
9.4
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
9.4
9
*
KCD30
NOMESCO Finland
Destruction of tumour of bladder
+∞
9.4
9
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
+∞
9.4
9
*
N20.1
ICD-10 Finland
Calculus of ureter
4.8
9.2
21
46
UKD02
NOMESCO Finland
Urethroscopy
38.0
9.1
11
*
N02AX02
ATC
tramadol; systemic, rectal
2.1
9.0
143
911
WX224
NOMESCO Finland
Blockade of obturius nerve
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
+∞
8.4
8
*
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
+∞
8.4
8
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.0
8.2
24
64
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.2
8.2
19
28
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.8
8.2
26
74
KED22
NOMESCO Finland
Transurethral resection of prostate
2.9
8.0
41
157
N18.8
ICD-10 Finland
Other chronic renal failure
4.4
7.9
20
48
N02BE01
ATC
paracetamol; systemic, rectal
2.8
7.8
261
2165
C03CA01
ATC
furosemide; systemic
2.0
7.8
137
892
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
46.2
7.8
9
*
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.5
7.7
19
31
A06AH03
ATC
naloxegol; oral
25.8
7.6
10
*
WX704
NOMESCO Finland
Intubation
3.4
7.6
28
88
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.5
7.5
52
233
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.2
7.5
20
50
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
82.1
7.5
8
*
PJA12
NOMESCO Finland
Sentinel node biopsy
82.1
7.5
8
*
KH1DD
NOMESCO Finland
CT urography of urinary organs
82.1
7.5
8
*
R33
ICD-10 Finland
Retention of urine
2.5
7.4
49
215
UKB12
NOMESCO Finland
Retrograde endoscopy of cutaneous ureteroenterostomy
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
ZZR00
NOMESCO Finland
Flap of skin
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
7.3
7
*
Z93.6
ICD-10 Finland
Other artificial openings of urinary tract status
+∞
7.3
7
*
U77
ICPC
Malignant neopl urinary tract other
+∞
7.3
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
G04BD12
ATC
mirabegron; oral
2.4
7.1
52
238
ZXE40
NOMESCO Finland
More than seven and less than nine hours
9.1
7.1
14
16
U70
ICPC
Pyelonephritis/pyelitis
9.1
7.1
14
16
R50.9
ICD-10 Finland
Fever, unspecified
2.5
7.0
50
226
WX702
NOMESCO Finland
Supraglottic ventilation device
3.8
6.9
21
58
JFB00
NOMESCO Finland
Partial resection of small intestine
17.2
6.8
10
6
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
17.2
6.8
10
6
KDE20
NOMESCO Finland
Removal of foreign body from urethra
41.0
6.8
8
*
TKE00
NOMESCO Finland
Needle biopsy of prostate
4.2
6.7
18
45
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
6.7
48
218
WX110
NOMESCO Finland
Infiltration anesthesia
1.9
6.6
183
1360
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
6.6
25
80
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
7.1
6.6
15
22
WX882
NOMESCO Finland
High dependency care
5.6
6.6
18
34
WW500
NOMESCO Finland
Blood transfusion
5.9
6.6
17
30
U29
ICPC
Urinary symptom/complaint other
4.1
6.5
18
46
U14
ICPC
Kidney symptom/complaint
7.7
6.5
14
19
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
71.3
6.5
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
71.3
6.5
7
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
71.3
6.5
7
*
B03XA02
ATC
darbepoetin alfa; parenteral
6.8
6.4
15
23
ZXA05
NOMESCO Finland
Left side
2.0
6.4
89
527
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
9.6
6.3
12
13
KA1FN
NOMESCO Finland
Isotope renography
18.5
6.3
9
5
D30.2
ICD-10 Finland
Benign neoplasm: Ureter
+∞
6.3
6
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
8120/2-C66.9
ICD-O-3
Urothelial carcinoma in situ of ureter
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
7323
FHL
Electrosection of TU bladder wall change
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
6.3
6
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
KBJ80
NOMESCO Finland
Operation for malfunction of urinary diversion
+∞
6.3
6
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
6.3
6
*
UKC12
NOMESCO Finland
Retrograde endoscopy of cutaneous cystoenterostomy
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
6.3
6
*
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
+∞
6.3
6
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.4
6.1
22
68
SPAT1262
SPAT
Handing over of treatment supplies
2.1
6.1
68
370
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
8.9
6.1
12
14
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
6.9
6.1
14
21
KDV10
NOMESCO Finland
Internal urethrotomy
6.9
6.1
14
21
ZXD05
NOMESCO Finland
Urgent procedure
1.9
6.1
94
576
ZXA00
NOMESCO Finland
Right side
1.9
6.0
92
560

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
193
89
61.21
285.87
6.7
1.8
—
—
—
0
0
109
147
11.19
82.35
2.2
1.1
—
—
—
0
0
61
58
13.01
57.89
1.4
1.3
—
—
—
0
0
199
701
6.69
56.38
7.1
3.4
—
—
—
0
0
177
588
6.05
52.75
3.8
1.6
—
—
—
0
0
183
714
5.14
42.55
10.1
3.1
223.68
161.44
e6/l
0.19
161
551
142
488
4.69
37.96
6.7
2.4
4.61
4.62
e6/l
0.00
133
431
162
648
4.34
34.60
10.1
3.0
0.35
0.38
e6/l
0.14
146
484
185
816
4.42
34.43
11.2
3.7
134.33
103.28
e6/l
0.48
163
585
150
611
3.97
30.29
10.2
3.0
—
—
—
0
0
195
949
4.13
30.27
4.2
2.3
—
—
—
0
0
128
481
3.94
28.81
7.2
2.8
536.75
541.59
mosm/kgh2o
0.11
114
398
148
632
3.70
27.18
3.5
2.1
—
—
—
0
0
244
1469
4.89
26.26
14.4
4.6
4.80
3047.90
e6/l
—
5
31
121
470
3.68
25.38
3.4
2.1
—
—
—
0
0
77
221
4.37
24.83
9.0
7.0
11.88
11.33
mmol/l
0.24
69
209
54
118
5.38
24.25
3.8
1.3
54.00
2.84
ug/l
0.80
46
95
149
698
3.30
22.59
6.9
3.8
—
—
—
0
0
104
393
3.55
22.34
9.4
3.0
1.27
1.73
e6/l
0.35
79
221
195
1086
3.36
21.78
9.5
3.8
9.36
12.60
umol/l
10.89
188
1015
203
1164
3.40
21.46
9.9
5.8
1.20
1.21
mmol/l
0.47
170
994
105
419
3.34
20.43
9.0
2.7
1.68
1.01
e6/l
1.30
78
244
237
1528
3.84
20.03
9.9
4.2
—
—
—
0
0
50
120
4.82
19.98
9.3
10.0
—
—
—
0
0
204
1228
3.16
18.76
23.3
18.5
1.23
1.42
inr
2.53
67
344
179
1013
2.96
18.22
7.2
3.7
32.50
35.01
g/l
6.65
168
935
191
1155
2.87
16.55
13.2
5.5
4.58
4.51
e9/l
0.13
164
995
64
213
3.56
16.26
11.3
7.8
—
—
—
0
0
177
1067
2.66
14.81
9.6
5.4
1.20
1.21
mmol/l
0.52
160
941
206
1400
2.58
12.47
8.0
4.5
6.95
6.87
mmol/l
0.26
200
1310
124
681
2.42
11.96
6.4
3.4
7.38
7.40
ph
1.19
25
108
157
962
2.36
11.73
6.4
5.2
8.94
8.92
%
0.02
151
872
153
928
2.35
11.69
6.1
4.9
0.54
0.65
%
1.66
148
844
156
955
2.35
11.65
6.2
5.0
2.48
2.97
%
2.00
148
869
171
1094
2.35
11.46
8.0
5.3
0.00
0.00
estimate
-0.00
42
177
157
974
2.31
11.24
6.3
5.2
22.16
25.75
%
3.59
152
888
72
315
2.70
11.11
7.7
6.4
13.33
11.24
kpa
2.75
67
305
228
1675
2.61
10.90
12.0
5.2
84.91
77.78
u/l
2.02
220
1521
155
965
2.28
10.90
6.0
5.0
62.67
58.62
%
4.01
150
883
171
1113
2.28
10.75
6.0
3.8
0.00
0.00
estimate
-0.00
43
174
71
315
2.65
10.62
7.9
6.5
-1.13
1.45
mmol/l
4.72
52
250
161
1032
2.24
10.38
5.9
4.8
0.67
0.63
e9/l
0.92
136
881
161
1037
2.22
10.20
5.9
4.8
0.04
0.04
e9/l
0.34
138
892
168
1101
2.23
10.19
6.1
3.9
0.00
0.00
estimate
-0.00
46
196
161
1054
2.17
9.58
6.0
4.9
1.64
1.78
e9/l
0.86
137
920
150
956
2.16
9.56
6.4
5.3
—
—
—
0
0
120
712
2.16
9.08
3.7
2.2
54.12
65.22
u/l
0.90
115
647
162
1081
2.11
8.97
5.9
5.0
0.18
0.21
e9/l
0.81
137
935
78
399
2.30
8.41
2.5
1.9
29.69
30.11
s
0.31
78
380
123
756
2.08
8.32
4.9
2.1
2.34
2.35
mmol/l
0.43
109
627
67
326
2.37
8.08
3.8
2.7
19.39
22.75
%
1.11
59
279
26
75
3.71
8.02
3.5
1.7
—
—
—
0
0
43
179
2.64
7.17
5.9
3.5
7.38
7.39
ph
—
8
23
15
21
7.46
6.79
1.9
1.3
—
—
—
0
0
56
273
2.30
6.65
7.0
3.5
0.76
2.03
mmol/l
2.17
47
228
57
281
2.28
6.59
2.0
1.8
—
—
—
0
0
13
16
8.44
6.40
1.1
1.1
—
—
—
0
0
13
17
7.94
6.19
1.2
1.8
—
—
—
0
0
84
493
1.99
6.15
1.4
1.2
—
—
—
0
0
255
2156
2.38
6.15
31.9
14.3
41.44
27.11
mg/l
6.52
240
1681
129
883
1.82
5.83
3.5
2.7
182.35
152.14
ug/l
0.64
117
793
23
77
3.16
5.67
2.4
2.5
0.44
0.24
g/l
—
8
22
78
469
1.90
5.23
10.2
4.2
—
—
—
0
0
79
482
1.87
5.05
3.8
2.1
2.51
2.44
mmol/l
3.47
64
404
34
151
2.42
4.95
1.9
1.4
—
—
—
0
0
19
62
3.21
4.88
5.1
2.7
—
—
—
0
0
17
52
3.41
4.82
4.3
2.7
—
—
—
0
0
98
648
1.77
4.79
2.4
2.2
2.84
3.03
mg/l
0.42
83
546
89
574
1.79
4.72
6.0
3.5
—
—
—
0
0
18
58
3.24
4.72
3.4
2.2
—
—
—
0
0
131
943
1.70
4.71
16.1
8.6
0.00
0.00
e9/l
0.55
99
772
23
86
2.82
4.70
1.6
1.4
—
—
—
0
0
148
1101
1.69
4.70
2.4
2.1
86.18
92.16
pmol/l
0.93
88
564
82
517
1.81
4.69
4.6
4.2
190.23
318.09
ng/l
0.34
71
449
30
129
2.48
4.68
6.5
3.8
—
—
—
0
0
111
770
1.71
4.53
5.0
4.2
—
—
—
0
0
11
19
5.97
4.48
1.1
1.7
—
—
—
0
0
93
622
1.72
4.30
2.6
2.6
378.81
10998.87
umol/l
3.84
75
522
31
146
2.26
3.97
2.0
1.5
—
—
—
0
0
43
233
1.99
3.86
5.8
3.3
—
—
—
0
0
199
1650
1.64
3.77
3.9
4.1
17.74
13.15
mm/h
3.04
182
1473
39
208
2.01
3.66
4.8
1.8
378.92
365.13
nmol/l
0.14
39
184
42
231
1.95
3.62
1.3
1.3
—
—
—
0
0
80
540
1.66
3.49
5.4
3.8
—
—
—
0
0
32
163
2.08
3.40
3.8
2.7
—
—
—
0
0
17
65
2.71
3.36
8.6
3.2
—
—
—
0
0
28
136
2.17
3.35
4.4
3.5
1.19
0.57
%
0.37
16
37
34
179
2.02
3.31
8.0
2.9
1.21
1.22
mmol/l
0.22
29
147
31
158
2.08
3.29
4.2
3.3
1.35
0.77
%
0.54
17
48
250
2233
1.80
3.24
30.6
14.3
—
—
—
0
0
12
34
3.63
3.23
3.4
3.0
—
—
—
0
0
210
1799
1.59
3.15
41.6
16.9
15.64
15.24
%
0.47
203
1758
40
231
1.85
2.99
6.6
3.2
—
—
—
0
0
29
150
2.04
2.97
4.4
3.4
0.07
0.05
%
0.08
15
39
258
2343
1.83
2.93
40.7
18.1
139.11
139.73
mmol/l
3.51
252
2256
53
336
1.70
2.90
2.6
2.2
1.85
1.67
%
0.50
46
299
6
9
6.78
2.88
10.2
2.4
—
—
—
0
0
258
2347
1.81
2.86
41.5
18.2
4.11
4.02
mmol/l
4.75
252
2261
116
889
1.50
2.85
2.4
3.1
3067.55
1932.95
ng/l
0.67
105
766
86
621
1.54
2.77
6.8
4.0
0.00
0.00
estimate
-0.00
35
175
194
1655
1.51
2.77
4.9
4.4
—
—
—
0
0
152
1243
1.46
2.64
3.4
3.1
63.01
50.57
u/l
0.62
145
1123
52
341
1.64
2.50
1.7
1.8
—
—
—
0
0
253
2311
1.68
2.47
43.8
17.2
119.89
86.99
umol/l
7.77
253
2311
32
184
1.83
2.44
6.6
3.7
—
—
—
0
0
26
140
1.94
2.41
4.2
3.4
0.00
0.04
%
0.49
13
28
40
248
1.71
2.37
2.8
2.5
72.78
65.45
e9/l
0.60
32
198
12
47
2.62
2.30
1.0
1.3
—
—
—
0
0
258
2379
1.69
2.29
48.1
21.2
91.74
91.84
fl
0.12
252
2316
258
2379
1.69
2.29
48.3
21.2
239.00
234.73
e9/l
0.42
250
2286
258
2380
1.69
2.28
48.1
21.1
30.04
30.57
pg
4.10
252
2317
258
2380
1.69
2.28
49.3
21.4
37.50
39.90
%
8.24
243
2161
258
2380
1.69
2.28
48.3
21.2
4.19
4.46
e12/l
12.19
250
2271
258
2381
1.68
2.26
48.3
21.2
7.34
6.87
e9/l
3.29
250
2276
258
2381
1.68
2.26
48.5
21.3
123.72
135.38
g/l
22.65
252
2317
32
190
1.77
2.21
1.9
1.5
—
—
—
0
0
7
19
3.75
2.16
8.9
2.6
—
—
—
0
0
8
26
3.13
2.03
1.1
1.0
—
—
—
0
0
23
128
1.86
1.96
2.6
1.9
1.60
1.52
g/l
0.17
18
108
25
144
1.80
1.92
4.3
2.7
0.69
0.64
%
0.24
25
144
30
184
1.70
1.87
2.6
1.4
—
—
—
0
0
25
148
1.75
1.77
4.3
2.8
1.13
1.06
%
0.07
25
148
12
54
2.27
1.76
5.3
2.0
—
—
—
0
0
9
36
2.55
1.75
1.4
2.6
—
—
—
0
0
88
697
1.37
1.67
1.7
1.6
18.41
20.65
nmol/l
0.78
77
579
248
2306
1.48
1.67
15.9
9.3
25.16
25.22
u/l
0.02
239
2172
6
20
3.04
1.59
4.0
3.5
—
—
—
0
0
19
107
1.83
1.59
2.9
2.6
325.37
767.48
ug/l
0.52
19
100
5
127
0.38
1.53
4.4
4.6
—
—
—
0
0
15
79
1.95
1.52
1.3
1.3
—
—
—
0
0
6
22
2.76
1.44
1.0
1.0
—
—
—
0
0
145
1260
1.30
1.41
4.8
4.2
2.25
2.09
ug/l
0.16
124
1103
8
36
2.26
1.25
2.0
1.5
1.73
1.75
mmol/l
—
8
36
6
25
2.43
1.25
1.3
1.2
—
—
—
0
0
215
1985
1.31
1.24
5.0
4.4
2.06
2.02
mu/l
0.10
193
1740
26
174
1.54
1.20
1.3
1.4
—
—
—
0
0
46
599
0.72
1.20
1.7
1.7
1.89
1.27
mmol/l
0.85
38
476
6
26
2.33
1.19
1.3
1.8
—
—
—
0
0
94
789
1.28
1.16
1.9
2.2
205.32
344.90
u/l
0.63
88
727
5
20
2.52
1.15
1.8
1.8
2.34
187.55
u/ml
—
5
20
74
604
1.30
1.13
1.9
1.8
1044.75
1203.83
nmol/l
0.83
51
453
7
31
2.29
1.11
1.6
1.3
—
—
—
0
0
104
898
1.24
1.00
4.1
3.9
17.36
8.20
mg/mmol
0.70
71
558
5
23
2.19
0.98
3.2
1.7
—
—
—
0
0
12
69
1.77
0.98
5.1
3.0
7.40
7.42
ph
0.55
12
59
7
37
1.91
0.94
1.7
2.0
34.14
33.00
pg
—
7
37
6
27
2.25
0.94
1.3
1.7
8.68
10.79
%
—
6
27
99
858
1.23
0.91
3.2
3.3
6.38
7.53
mmol/l
2.35
78
695
20
136
1.50
0.89
8.4
3.7
—
—
—
0
0
172
1582
1.21
0.86
3.8
3.5
15.18
15.08
pmol/l
0.18
151
1378
97
846
1.22
0.83
3.2
3.3
96.74
131.87
mg/l
0.17
68
533
23
315
0.71
0.83
1.2
1.3
3.14
13.37
u/ml
—
8
96
116
1032
1.20
0.81
4.2
4.1
49.13
85.40
ng/l
0.54
97
800
27
201
1.38
0.78
4.8
4.2
—
—
—
0
0
72
618
1.22
0.72
1.8
1.8
357.25
12048610.85
pmol/l
0.50
56
498
10
61
1.66
0.69
3.8
3.7
21.90
27.01
mg/l
—
5
43
10
61
1.66
0.69
1.6
1.6
—
—
—
0
0
79
689
1.20
0.67
2.4
2.7
0.66
0.74
ug/l
0.52
57
478
7
43
1.64
0.67
2.9
2.2
—
—
—
0
0
5
29
1.74
0.64
2.0
1.4
89.14
90.27
%
—
5
29
5
29
1.74
0.64
1.2
1.3
—
—
—
0
0
16
219
0.72
0.60
1.3
1.4
—
—
—
0
0
6
35
1.73
0.58
1.5
1.2
818.00
2270.46
e6/l
—
6
24
6
36
1.68
0.57
1.0
1.2
—
—
—
0
0
11
73
1.53
0.57
9.6
4.4
—
—
—
0
0
38
314
1.24
0.55
1.4
1.2
—
—
—
0
0
52
445
1.20
0.55
1.4
1.7
2.68
1.41
mg/l
0.92
41
345
9
60
1.52
0.55
5.8
1.3
—
—
—
0
0
6
39
1.55
0.53
1.5
1.3
32.33
27.03
g/l
—
6
34
7
45
1.57
0.49
2.9
2.2
108.57
105.53
mmol/l
—
7
45
7
45
1.57
0.49
2.9
2.2
4.10
4.11
mmol/l
—
7
45
7
48
1.47
0.47
1.1
1.1
—
—
—
0
0
31
256
1.24
0.46
1.3
1.5
—
—
—
0
0
5
31
1.62
0.43
1.6
1.3
17636.60
75684.33
e6/l
—
5
18
5
32
1.57
0.42
1.2
1.2
—
—
—
0
0
55
619
0.86
0.41
3.9
3.5
—
—
—
0
0
0
19
0.00
0.39
0.0
14.0
—
—
—
0
0
5
37
1.36
0.37
1.0
1.2
—
—
nmol/l
—
0
0
6
42
1.44
0.35
1.0
1.1
—
—
—
0
0
41
359
1.17
0.35
1.1
1.2
2.36
2.85
g/l
0.92
26
208
225
2188
1.12
0.33
5.5
5.2
6.22
6.17
mmol/l
0.23
197
1931
7
100
0.69
0.31
1.1
1.2
117.00
193.43
u/ml
—
7
91
212
2062
1.10
0.28
4.2
4.5
1.29
1.24
mmol/l
0.55
186
1823
12
95
1.27
0.26
1.2
1.3
—
—
—
0
0
11
138
0.79
0.26
1.1
1.3
—
—
—
0
0
11
87
1.27
0.24
2.9
2.7
3.46
4.36
pmol/l
2.34
11
74
5
38
1.32
0.23
1.2
1.5
—
—
—
0
0
59
547
1.10
0.23
7.7
4.2
1.02
1.02
kg/l
0.11
12
87
5
40
1.25
0.22
1.0
1.2
0.80
0.54
nmol/l
—
5
35
5
42
1.19
0.21
6.6
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
5.04
—
0
6
0
12
0.00
0.21
0.0
1.0
—
0.47
—
0
7
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
0.54
—
0
7
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
16
136
1.19
0.20
1.2
1.2
—
—
—
0
0
6
48
1.26
0.20
1.3
3.4
—
—
—
0
0
217
2128
1.08
0.19
7.6
6.8
41.39
41.20
mmol/mol
0.12
191
1924
16
142
1.13
0.13
2.8
2.5
—
—
—
0
0
42
397
1.07
0.11
1.1
1.3
0.93
1.89
u/ml
—
10
107
211
2138
0.95
0.11
4.8
5.0
1.34
1.41
mmol/l
1.44
192
1906
213
2156
0.96
0.10
4.8
5.0
4.13
4.34
mmol/l
2.28
191
1943
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
5
65
0.77
0.08
1.0
1.2
—
—
—
0
0
7
66
1.06
0.08
3.3
3.3
0.93
0.92
nmol/l
—
7
51
7
67
1.05
0.08
1.3
1.3
—
—
—
0
0
11
122
0.90
0.07
1.3
1.3
—
41.11
—
0
9
13
141
0.92
0.05
2.4
2.5
—
7.58
—
0
5
223
2218
1.02
0.03
5.3
5.7
2.33
2.51
mmol/l
2.73
201
1986
17
165
1.03
0.00
1.4
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
2354.38
—
0
8
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
59
0.84
-0.00
1.0
1.1
—
3.93
—
0
9
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
—
—
0
0
5
57
0.88
-0.00
1.4
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
1.17
—
0
6

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_URETER_WIDE – Malignant neoplasm of ureter, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).